1. Shah RR, Morganroth J. Evaluating the QT-liability of a drug during its development. Pharm Med. 2008;22:151–64.
2. Dessertenne F. La tachycardie ventriculaire a deux foyers oppocees variable. Arch Mal Coeur Vaiss. 1966;59:263–72.
3. Salle P, Rey JL, Bernasconi P, et al. Torsades de pointe. Apropos of 60 cases. Ann Cardiol Angeiol (Paris). 1985;34:381–8.
4. Milon D, Daubert JC, Saint-Marc C, et al. Torsade de pointes. Apropos of 54 cases. Ann Fr Anesth Reanim. 1982;1:513–20.
5. Fung MC, Hsiao-hui Wu H, Kwong K, et al. Evaluation of the profile of patients with QTc prolongation in spontaneous adverse event reporting over the past three decades – 1969–98. Pharmacoepidemiol Drug Saf. 2000;9(Suppl 1):S24.